Protalix Biotherapeutics Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$19,896	$33,750	$9,122	$17,851
Gross Profit	12,134	29,623	4,503	9,527
EBITDA	5,760	21,738	-4,006	2,791
EBIT	5,354	21,334	-4,393	2,419
Net Income	3,777	18,317	-5,504	2,355
Net Change In Cash	19,896	33,750	9,122	17,851
Free Cash Flow	-10,993	21,264	1,627	-4,230
Cash	27,420	41,712	14,680	13,647
Basic Shares	82,560	83,048	78,546	80,814

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$52,744	$53,399	$65,494	$47,638
Gross Profit	25,236	29,080	42,512	28,046
EBITDA	-2,952	6,520	12,937	-10,782
EBIT	-4,417	5,216	11,746	-11,868
Net Income	-6,604	2,932	8,312	-14,927
Net Change In Cash	52,744	53,399	65,494	47,638
Free Cash Flow	-13,631	7,392	-2,467	-25,628
Cash	14,680	19,760	23,634	17,111
Basic Shares	78,546	81,057	82,424	48,472